Avid Bioservices Inc (CDMO)

[biopharm]

Lastly, why set up a trial that, if expected to perform, cannot exceed a placebo?

Phase II exceeded the placbo by 109% MOS improvement and Peregrine filed for phase III based upon 60% MOS conservative improvement of MOS

So you see....where does it say they set up phase III to equal performance of placebo ? Lol sounds like some non truths in your opinion